(+/-)-Methoxyverapamil,Hydrochloride; Gallopamil Hydrochloride; D 600 Hydrochloride; D600,Hcl; (+/-)-Methoxyverapamil Hcl; Gallopamil Hcl; Gallopamil; D600; (S)-Gallopamil; Procorum

Brief Introduction

Gallopamilhydrochloride is a methoxy derivative of verapamil and a phenylalkylamine calcium antagonist. Gallopamilhydrochloride inhibited acid secretion in a concentration dependent manner with an IC50 of 10.9 μ M。 Gallopamilhydrochloride is an effective antiarrhythmic and vasodilator.

Anidulafungin

CAS:166663-25-8

Molecular Formula:C58H73N7O17

Alias

More Information

V-Echinocandin; Anidulafungin; Ver-002; Ecalta; Eraxis; Unii-9Hlm53094I

Brief Introduction

Anifenjing is an echinocandin antifungal drug, and its mechanism of action is the same as "caspofungin". It has antibacterial activity against Candida and Aspergillus, but not against Cryptococcus, Fusarium and trichosporum.

(4S,7S,10As)-5-Oxo-4-[[(2S)-3-Phenyl-2-Sulfanylpropanoyl]Amino]-2,3,4,7,8,9,10,10A-Octahydropyrido[2,1-B][1,3]Thiazepine-7-Carboxylic Acid

CAS:167305-00-2

Molecular Formula:C19H24N2O4S2

Alias

More Information

Omapatrilat; Omapatrilat (Jan/Usan/Inn); Vanlev; Bms-186716; Bms 186716

Brief Introduction

Omapatrilat (INN) is a novel antihypertensive agent that inhibits both neutral endopeptidase (NEP) and angiotensin converting enzyme. NEP inhibition results in elevated natriuretic peptide levels, promoting natriuresis, diuresis, vasodilation, and reductions in preload and ventricular remodeling. This drug from Bristol-Myers Squibb was not approved by the U.S. Food and Drug Administration due to angioedema safety concerns. Omapatrilat angioedema was attributed to its dual mechanism of action, inhibiting both angiotensin converting enzyme (ACE), and neutral endopeptidase, both of these enzymes are responsible for the metabolism of bradykinin which causes vasodilation, angioedema, and airway obstruction.

Ornidazole

CAS:16773-42-5

Molecular Formula:C7H10ClN3O3

Alias

More Information

1-(3-Chloro-2-Hydroxypropyl)-2-Methyl-5-Nitroimidazole; 1-Chloro-3-(2-Methyl-5-Nitro-1H-Imidazol-1-Yl)-2-Propanol; 1-Chloro-3-(2-Methyl-5-Nitro-1H-Imidazol-1-Yl)Propan-2-Ol; 1-Chloro-3-(2-Methyl-5-Nitroimidazol-1-Yl)Propan-2-Ol; Ornidazol A-(Chloromethyl)-2-Methyl-5-Nitro-1H-Imidazole-1-Ethanol; Alpha-(Chlormethyl)-2-Methyl-5-Nitro-Imidazol-1-Aethanol; Alpha-(Chloromethyl)-2-Methyl-5-Nitro-1H-Imidazole-1-Ethano; Ro7-0207

Brief Introduction

Ornidazole is the third generation of nitroimidazole, which has obvious antibacterial advantages over metronidazole and Tinidazole. The half-life of plasma elimination of ornidazole is 14.4 hours, which is higher than that of metronidazole (8.4 hours) and Tinidazole (12.7 hours). Therefore, ornidazole can reduce the times of taking medicine and is more convenient to use. It acts on the DNA of anaerobes, amoebas, Giardia and Trichomonas cells to break their helix structure or prevent their transcription and replication, resulting in the death of pathogenic bacteria. The peak plasma concentration was reached 2 hours after oral administration, and the bioavailability was about 90%.

Inquiry (

/ 10

)

Clear All